Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer

International Journal of Cancer- United States

doi 10.1002/ijc.31575

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor-Positive Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2011English

Androgen Receptor-Positive, Triple-Negative Breast Cancer

Cancer
Cancer ResearchOncology
2017Norwegian

Dicer Expression in Estrogen Receptor–positive Versus Triple-Negative Breast Cancer: An Antibody Comparison

Human Pathology
Forensic MedicinePathology
2016Breton

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2019English

How to Target Estrogen Receptor-Negative Breast Cancer?

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2003English

Characterization of the Interactions Between Calmodulin and Death Receptor 5 in Triple-Negative and Estrogen Receptor-Positive Breast Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Phase II Study of Pembrolizumab and Capecitabine for Triple Negative and Hormone Receptor-Positive, HER2−negative Endocrine-Refractory Metastatic Breast Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Triple-Negative Breast Cancer

2018English

Adjuvant Chemotherapy Decisions in Clinical Practice for Early-Stage Node-Negative, Estrogen Receptor-Positive, HER2-Negative Breast Cancer: Challenges and Considerations

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy